The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.
about
18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment responseUsing patient management as a surrogate for patient health outcomes in diagnostic test evaluationTherapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapyPET/CT without capacity limitations: a Danish experience from a European perspective.PET Imaging of Prostate Cancer Using C-Acetate.Appropriateness criteria of FDG PET/CT in oncology.FDG PET/CT in cancer: comparison of actual use with literature-based recommendations.Molecular theranostics: a primer for the imaging professionalHow to study optimal timing of PET/CT for monitoring of cancer treatmentFocal colorectal uptake in (18)FDG-PET/CT: maximum standard uptake value as a trigger in a semi-automated screening setting.Intended versus inferred management after PET for cancer restaging: analysis of Medicare claims linked to a coverage with evidence development registry.Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal CancersEvaluation of Cross-Calibrated 68Ge/68Ga Phantoms for Assessing PET/CT Measurement Bias in Oncology Imaging for Single- and Multicenter TrialsPET/CT is a cost-effective tool against cancer: synergy supersedes singularityCombined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, GermanyModification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy.Incidental focal colonic lesions found on (18)Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management.Comparison of restaging accuracy of repeat FDG-PET/CT with pelvic MRI after preoperative chemoradiation in patients with rectal cancer.
P2860
Q30250993-5A0A6B9C-CFC5-493F-BC06-734F272B9900Q34158661-7B05ED6D-2FDD-4603-94ED-C58F1DCA9616Q34220071-A861401D-23EB-438A-A37E-B115D4FBF781Q34517660-F83E62EA-5D25-45DA-B23D-9B3AC8002622Q34940350-3524E533-0D68-49C5-862A-C61884032256Q35288176-78E7D6B7-05D9-4152-9E59-7C11DC419094Q35568776-EABC0998-B5F3-48BA-9A8D-D299510FE431Q35828077-884811E6-FE75-4CA9-8DDC-0E4F6C002663Q36251545-FDF5BC38-B17E-46B8-8930-C427B41D7573Q36337232-2EDA6BC9-5554-4919-8275-1F15F7878FE8Q36447283-97A63CFA-FEC3-4900-B9A2-C70E421730ADQ36869758-3BF68EDA-99E8-49A1-9253-0E683CC8D390Q37103058-98C2CC12-E9E8-42E8-A222-AD64B6A3DFFDQ37558197-C8C5E2A9-24A0-46AA-902E-3C4FB8ADE392Q42388521-3FF9FCEA-F2BF-4421-AA38-DB5D93F509BFQ42566769-835AC5F4-A096-4522-9437-E65CE5731E7AQ44756951-C2150B7C-490D-45D0-A5C6-BE3185446DE2Q51540894-6437B2D2-DA25-4A4F-967C-E59CE47E35EDQ53053248-94300799-E1D4-466F-9F89-B3A98F78F9DB
P2860
The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
The impact of positron emissio ...... tional Oncologic PET Registry.
@en
type
label
The impact of positron emissio ...... tional Oncologic PET Registry.
@en
prefLabel
The impact of positron emissio ...... tional Oncologic PET Registry.
@en
P2093
P2860
P356
P1433
P1476
The impact of positron emissio ...... tional Oncologic PET Registry.
@en
P2093
Anthony F Shields
Barry A Siegel
Bruce E Hillner
Lucy Hanna
R Edward Coleman
Sharon Hartson Stine
P2860
P304
P356
10.1002/CNCR.24000
P407
P577
2009-01-01T00:00:00Z